Chinese Traditional and Herbal Drugs
|
2025, 56(1): 1-8
Proposition and practice of “macro-quality view” in quality control for traditional Chinese medicines under new situation
Full
XIAO Xiaohe1,2,3, LI Hanbing4, ZHAO Xu1, BAI Zhaofang1,2, WANG Jiabo5
Affiliations
1 China Military Institute of Chinese Medicine, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China;
2 Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China;
3 Research Center for Precision Medication of Chinese Medicine, Hunan University of Traditional Chinese Medicine, Changsha 410208, China;
4 School of Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, China;
5 School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China
About Author:
中央本级重大增减支项目"名贵中药资源可持续利用能力建设项目" (2060302); 国家自然科学基金重点项目 (81930110); 国家自然科学基金重点项目 (82230118)
doi: 10.7501/j.issn.0253-2670.2025.01.001
Outline
The quality of traditional Chinese medicine (TCM) is a crucial cornerstone for the high-quality development of TCM industry and practice. Under the new situation, how can we develop a scientific and rational understanding of the overall state and existing challenges related to the quality of TCM? Furthermore, how can we solve the problems of quality control and standardization that have long restricted the modernization of TCM? From the perspective of underlying logic, this paper re-examines the characteristics of material connotation of TCM and the rationality of quality control strategies, and supplements and modifies the previous understanding to propose a new “macro-quality view” for TCM by supplementing and modifying the previous understanding. This perspective encompasses: a set of innovative cognitions, two-tier regulatory scales, three-dimensional quality connotations, four-phase process quality control strategies, and five-level evidence system for quality control effectiveness. It is hoped that this new perspective will offer novel theories, strategies, and methods for tackling the challenges associated with the quality evaluation and standardization of TCM.
standardization of traditional Chinese medicine
/
quality control
/
new strategies
/
macro-quality view
/
effective component index
肖小河, 李寒冰, 赵旭, 柏兆方, 王伽伯.
新形势下的中药大质量观及实践.
中草药,
2025
, 56
(1)
: 1
-8
.
DOI: 10.7501/j.issn.0253-2670.2025.01.001
XIAO Xiaohe, LI Hanbing, ZHAO Xu, BAI Zhaofang, WANG Jiabo.
Proposition and practice of “macro-quality view” in quality control for traditional Chinese medicines under new situation[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(1)
: 1
-8
.
DOI: 10.7501/j.issn.0253-2670.2025.01.001
Year 2025 volume 56 Issue 1
42
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.01.001
- Receive Date:2024-06-19
- Online Date:2026-11-12